BJMO - , issue ,
K. Van Baelen , N. Van den Rul , S. Marquette , L. Vansteelant , J. Mebis MD, PhD, C. Thywissen , A.-S. Vliegen , L. Noé , M. Drijkoningen , G. Orye
In clinical practice, the diversity in the surgical management of the axilla after neo-adjuvant chemotherapy (NACT) for node positive patients is huge. Given the morbidity of axillary lymph node dissection (ALND), a trend to perform a less invasive technique is seen in both literature and clinical practice. There are three major techniques: 1) sentinel lymph node biopsy (SLNB), 2) guided removal of lymph nodes that were positive prior to NACT, and 3) Targeted Axillary Dissection (TAD) which is a combination of the previous two techniques. Criteria for patients eligible for these techniques vary widely and oncological safety cannot always be guaranteed. With this report, we aim to introduce TAD in a safe way into the clinical practice.
Read moreBJMO - 12, issue 3, february 2018
J. Robijns , S. Censabella , S. Claes , L. Pannekoeke , L. Bussé , D. Colson , I. Kaminski , A. Maes MD, P. Bulens , M. Brosens , L. Noé , I. Lambrichts , A. Timmermans , V. Somers , J. Mebis MD, PhD
BJMO - 12, issue 3, february 2018
J. Mebis MD, PhD, S. Censabella , S. Engels , C. Van Narsenille , G. Orye , S. Marquette , L. Vansteelant , L. Noé , A. Maes MD, P. Bulens , E.J.R. Joosens , D. Luyten MD
BJMO - volume 11, issue 8, december 2017
J. Robijns , S. Censabella , P. Bulens , A. Maes MD, L. Noé , M. Brosens , L. Van den Bergh MD, PhD, S. Claes , J. Mebis MD, PhD
Photobiomodulation therapy is based on the application of visible and/or (near-)infrared light on the target tissue. We performed a review of 34 articles on the use of photobiomodulation therapy in the management of cancer related lymphoedema, oral mucositis, radiodermatitis, chemotherapy-induced peripheral neuropathy, osteonecrosis of the jaw, and xerostomia/hyposalivation. The findings suggest that photobiomodulation therapy is a promising option for the management of these cancer therapy-related side effects.
(BELG J MED ONCOL 2017;11(8):364–374)
Read more
Top
